Sponsor Pipeline

Asociación para Evitar la Ceguera en México Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
4
Recruiting
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-02 NCT00346814
Antiangiogenic Therapy With Bevacizumab in Retinopathy of Prematurity. Structural Outcome		 overall status: Recruiting → Unknown
Active Trials by Phase
Phase 1
2
Not specified
3
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT05587205 Safety and Tolerability of EO2002 Cataract Recruiting
NCT05636579 Study to Assess Safety and Tolerability of Multiple Doses of EO2002 Corneal Edema Recruiting
Not specified
NCT07095907 Post-surgical Functional Results in Patients With Epiretinal Membrane Undergoing… Epiretinal Membrane Surgery Recruiting
NCT07175311 Vascular Changes Associated With Endophthalmitis. Endophthalmitis Recruiting
NCT07430137 Blink Reminders and Meibomian Gland Loss in Digital Screen Users Dry Eye Syndromes Not Yet Recruiting
Get alerts when Asociación para Evitar la Ceguera en México's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free